116 results about "Tissue composition" patented technology

Novel implantable tissue fixation methods and compositions are disclosed. Methods and compositions of tissue, fixed using polymeric and/or variable length crosslinks, and di- or polymercapto compounds are described. Also described are the methods and compositions wherein the tissue is fixed using biodegradable crosslinkers. Methods and compositions for making radioopaque tissue are also described. Methods and compositions to obtain a degradable implantable tissue-synthetic biodegradable polymer composite are also described. Compositions and methods of incorporating substantially water-insoluble bioactive compounds in the implantable tissue are also disclosed. The use of membrane-like implantable tissue to make an implantable drug delivery patch are also disclosed. Also described are the compositions and methods to obtain a coated implantable tissue. Medical applications implantable tissue such as heart valve bioprosthesis, vascular grafts, meniscus implant, drug delivery patch are also disclosed.

Compositions and methods of treating a defect in a patient are disclosed, including expanding a culture of autologous cells in vitro to form cultured cells, collecting the cultured cells for introduction into the patient, and depositing the cultured cells with ancillary proteins.

A method of enhancing image quality and providing tissue composition information by analysis of energy discrimination data, the method comprising determining a radiation dosage at one or more energy spectrum levels based on patient parameters and user selected parameters. Computer-readable medium and systems that afford functionality of the type defined by this method are also contemplated in conjunction with the present technique.

The present invention includes an apparatus, method and system for monitoring and controlling radiation therapy, the system including a radiative source that emits energy that enters a tissue and is absorbed at or a near a target site in the tissue to heat the tissue; an ultrasound transmitter directed at the target site, wherein the ultrasound transmitter emits ultrasound signals to the tissue that has been heated by the radiative source; an ultrasound receiver directed at the target site, wherein the ultrasound receiver receives ultrasound signals emitted from the ultrasound transmitter and reflected from the tissue that has been heated by the radiative source; and a signal processor that processes the received ultrasound signal to calculate a tissue composition scan or tissue temperature scan.

The current invention provides devices, methods and systems involving application of energy and/or a liquefaction promoting medium to a tissue of interest to generate a liquefied sample comprising tissue constituents so as to provide for rapid tissue sampling, tissue decontamination as well as qualitative and/or quantitative detection of analytes that may be part of tissue constituents (e.g., several types of biomolecules, drugs, and microbes). In addition, the current invention provides specific compositions of the said liquefaction promoting medium so as to facilitate liquefaction, preserve liquefied tissue constituents, and enable delivery of molecules into tissues. Determination of tissue composition in the liquefied tissue sample can be used in a variety of applications, including diagnosis or prognosis of local as well as systemic diseases, evaluating bioavailability of therapeutics in different tissues following drug administration, forensic detection of drugs-of-abuse, evaluating changes in the tissue microenvironment following exposure to a harmful agent, and various other applications. The methods, devices and systems are used to deliver one or more drugs through or into the site of the tissue to be liquefied.

The invention discloses an active composition containing copper peptide and a cosmetic or skin care product. The active composition containing copper peptide is prepared from the following components in percentage by weight: 0.001-2 percent of copper peptide, 1-5 percent of vitamin E, 0.1-10 percent of chitin oligosaccharide, 0.1-2 percent of 4-MSK, 0.1-5 percent of algal polysaccharides, 6-30 percent of emulsifier, 0-10 percent of co-emulsifier, 0.1-0.8 percent of stabilizer, 0-10 percent of excipient and the balance of water. The active composition and the cosmetic or skin care product have the effects of promoting cell reproduction, remarkably moisturizing and moistening, delaying senescence and the like.

A method for noninvasively determining deep tissue temperature comprises measuring data relating to spectral shifts of chromophore absorption in tissue using broadband diffuse optical spectroscopy and generating a temperature reading corresponding to the spectral shift of an absorption peak of the chromophore. A bound water correction is made to the spectral shift. A frequency domain measurement at multiple wavelengths is made to determine the absolute absorption and scattering values between 600 and 1050 nm. The measurement of an absolute absorption comprises measuring an absolute absorption coefficient of selected tissue and further comprising deducing concentrations of tissue composition including lipids, deducing information related to heterogeneity and integrity of tissue matrix, and deducing temperature heterogeneity related to vulnerable plaque in vascular tissue. The measurement comprises making a measurement in the range of 600-1100 nm to interrogate a vessel wall in the presence of blood.

Method and devices for cutting and removing a portion of a tissue composition which includes cancellous bone which is directly or indirectly impinging on a neural structure of the spine by creating channels through the tissue structure and then removing the detached tissue.

A method of reducing damage to cells and tissue caused by an ischemic or hypoxic event is disclosed. The method includes administering to the cell or tissue, either in vivo or ex vivo, ψεRACK peptide. The peptide can be administered before, during or after the ischemic or hypoxic event.

The present invention relates to surgical material. The material includes biological absorbable polymer 10-90 wt%, un-sintered calcium phosphate salt 9-80 wt% and active matter less than 50 wt%. The biologically absorbable polymer includes polyester, chitosan, chondroitin sulfate, collagen, alginate, etc.; and the calcium phosphate salt is un-sintered hydroxyapatite or tricalcium phosphate of granularity less than 100 microns. The hard tissue repairing material is prepared through mixing biologically absorbable polymer, un-sintered calcium phosphate salt, etc. dispersed in solvent, freeze drying to eliminate solvent and obtain porous material and mixing with active matter. The composition has the function of promoting bone healing and excellent biocompatibility.

The invention discloses an active composition for adjusting microorganism ecological balance of a skin surface, and aims to provide an active composition capable of effectively promoting growth and reproduction of beneficial bacteria, inhibiting multiplication of harmful bacteria and adjusting microorganism ecological balance of the skin surface. The composition comprises, by weight, 3-15 parts of fructo-oligosaccharide, 5-12 parts of monosaccharide compositions, 1-8 parts of lactobacillus/soybean milk fermentation product filtrate and 30-50 parts of polyhydric alcohols. The invention belongs to the technical field of biology.

Compositions, methods and systems for treating disordered epithelial tissues, such as is caused by pathogens and/or by toxins produced thereby. The invention relates to the use of an anti-infective and/or antimicrobial active agent in a carrier, with vigorous agitation of the disordered epithelial tissue for topical treatment thereof under such conditions sufficient to achieve clinically discernable improvement of the disordered epithelial tissue. The preferred anti-infective and/or antimicrobial active agent comprises a nucleoside, such as acyclovir, valcyclovir, penciclovir, famciclovir, ganciclovir, cidofovir, adefovir, and tenofovir, and derivatives, analogs, or metabolites thereof, or a mixture thereof, or 1-docosanol, optionally in combination with an organohalide. The inventive compositions and methods may employ the use of an applicator adapted for use in promoting the penetration of the treatment composition and/or the vigorous agitation of the disordered tissue.

The invention relates to the field of anti-tumor compositions, and discloses a triterpene-enriched anti-tumor composition. The composition is prepared from the following components in parts by weight: 10-15 parts of antrodia sporocarp extract, 10-25 parts of antrodia mycelium extract and 60-80 parts of lucid ganoderma sporocarp extract. The composition comprises 10-17 percent by weight of a triterpene compound. Fat-soluble extracts of two types of fungi are mixed in a proper ratio to form the composition, the anti-tumor effect of the unit value composition is greatly improved, the content of tumor markers can be remarkably reduced, the economic burden of tumor patients can be reduced, and body injury caused by excessive residues when over lucid ganoderma medicines are taken can be avoided.

A tissue composition monitoring apparatus that includes a catheter with an optical sensor for tissue composition monitoring and ablation lesion determination via an automated algorithm incorporating Arrhenius model thermal denaturation kinetics for determining the characteristics of tissue for example the transmurality of the ablation lesion.

The present invention provides a liver-derived devitalized mammalian parenchymatous tissue composition which includes an interstitial structure of connective tissue which can serve as a scaffold for tissue repair or regeneration. The devitalized mammalian parenchymatous tissue composition can further include the basement membrane of the tissue.